We are focused on providing more effective treatments for patients who have few options, and our pipeline targets tumours including diffuse B-cell lymphomas, lung cancer, gynaecological tumours such as those of the ovary & cervix, pancreatic, triple-negative breast cancer and colorectal cancer.